- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01667835
South Asian Women & Yoga Education Study (SAWYES)
16 novembre 2012 aggiornato da: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University
Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study
The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Panoramica dello studio
Stato
Sconosciuto
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Anticipato)
50
Fase
- Fase 1
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3T 0G9
- Reclutamento
- The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
-
Contatto:
- Amandah L Hoogbruin, PhD
- Numero di telefono: 604 599 3144
- Email: amandah.hoogbruin@kwantlen.ca
-
Contatto:
- Raymond Dong, FRCP(c)
- Numero di telefono: 604 686 6372
- Email: raydongheart@gmail.com
-
Surrey, British Columbia, Canada, V3W 2M8
- Non ancora reclutamento
- Kwantlen Polytechnic University
-
Contatto:
- Amandah L Hoogbruin, PhD
- Numero di telefono: 604 599 3144
- Email: amandah.hoogbruin@kwantlen.ca
-
Contatto:
- Raymond Dong, FRCPC
- Numero di telefono: 604 838 8418
- Email: raydongcardio@gmail.com
-
Investigatore principale:
- Amandah L Hoogbruin, PhD
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 40 anni a 65 anni (Adulto, Adulto più anziano)
Accetta volontari sani
Sì
Sessi ammissibili allo studio
Femmina
Descrizione
Inclusion Criteria:
- 40- 65 years old
- Postmenopausal (amenorrhea for ≥ 12 months)
- Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
- Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
- Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
- Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.
Exclusion Criteria:
- Have had a period within the last year
- Are not between the ages of 40 and 65
- Have experience with yoga within the last 12 months
- Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
- Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
- Have a severe infectious or other medical illness right now such as pneumonia
- Use medications to lower blood sugar levels
- Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
- Regularly use an assistive device (e.g., cane, walker) to walk
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Controllo
|
|
|
Sperimentale: Intervento sullo yoga
|
12 week 90 minute hatha yoga session offered three (3x) per week.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in blood pressure
Lasso di tempo: baseline, at end of study (12 wks), & 3 months post-study
|
blood pressure is measured as a specific physiologic index of cardiovascular risk.
|
baseline, at end of study (12 wks), & 3 months post-study
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in subjective well-being
Lasso di tempo: baseline, at end of study (12 wks), & 3 months post-study
|
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
|
baseline, at end of study (12 wks), & 3 months post-study
|
|
Change in perceived physical well-being
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in insulin sensitivity
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in inflammation
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum total cholesterol
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum total cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum high-density lipoprotein (HDL) cholesterol
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum low-density lipoprotein (LDL) cholesterol
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum triglycerides
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum triglycerides will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in waist circumference.
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change waist-hip ratio
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in body mass index (BMI)
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in resting heart rate
Lasso di tempo: baseline, end of study (12 wks) & 3 months post-study
|
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in heart rate
Lasso di tempo: baseline, at end of study (12 wks), & 3 months post-study
|
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, at end of study (12 wks), & 3 months post-study
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 novembre 2012
Completamento primario (Anticipato)
1 dicembre 2014
Completamento dello studio (Anticipato)
1 agosto 2015
Date di iscrizione allo studio
Primo inviato
17 giugno 2012
Primo inviato che soddisfa i criteri di controllo qualità
14 agosto 2012
Primo Inserito (Stima)
17 agosto 2012
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
19 novembre 2012
Ultimo aggiornamento inviato che soddisfa i criteri QC
16 novembre 2012
Ultimo verificato
1 novembre 2012
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- KK11-04
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Yoga Intervention
-
VA Office of Research and DevelopmentCompletatoDisturbi da Stress, Post-traumaticiStati Uniti
-
University of ZurichETH Zurich (Switzerland)Reclutamento
-
Superior UniversityAttivo, non reclutanteArtrosi al ginocchioPakistan
-
Oregon Health and Science UniversityNational Institute of Mental Health (NIMH); University of Connecticut; University... e altri collaboratoriNon ancora reclutamento
-
KK Women's and Children's HospitalCompletatoCambio di pesoSingapore
-
Ege Miray TopcuCompletatoAnsia | Terapia di supporto gestita da infermiere | Interventi infermieristiciTurchia (Türkiye)
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD); American...Non ancora reclutamentoIpertensione | Ipertensione complicata con il diabete di tipo 2Stati Uniti
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Virginia Commonwealth UniversityReclutamentoObesità | Cancro | Attività fisica | Dieta | Sopravvivenza al cancroStati Uniti
-
University of PittsburghCompletatoDistrofia muscolare di DuchenneStati Uniti
-
PeriPharmNon ancora reclutamentoEczema | Dermatite atopica | Caregiver | Fardello | Eczema Dermatite Atopica